Elutia to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Elutia (Nasdaq: ELUT), a leader in drug-eluting biomatrix products, has announced its participation in two upcoming investor conferences in New York. Dr. Randy Mills, President and CEO, and Matt Ferguson, CFO, will represent the company at these events:

1. H.C. Wainwright 26th Annual Global Investment Conference:
- Presentation available on-demand from September 9, 2024, 7:00 a.m. ET
- One-on-one meetings on September 11, 2024

2. Lake Street Capital Markets 8th Annual Best Ideas Growth Conference:
- One-on-one meetings on September 12, 2024

Institutional investors can arrange meetings with Elutia's management through their H.C. Wainwright and Lake Street representatives.

News Market Reaction – ELUT

-1.48%

-1.48% Session move

In the trading session that priced this news, ELUT declined 1.48%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SILVER SPRING, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences in New York:

H.C. Wainwright 26^th Annual Global Investment Conference
Format: Presentation and 1x1 Meetings
Presentation Date and Time (On-demand beginning): Monday, September 9, 2024, 7:00 a.m. ET
1x1 Meetings: Wednesday, September 11, 2024
Webcast: Click here

Lake Street Capital Markets 8^th Annual Best Ideas Growth Conference
Format: 1x1 Meetings
Date: Thursday, September 12, 2024

Institutional investors interested in meeting with management during the conferences may reach out to their respective H.C. Wainwright and Lake Street representatives.

About Elutia

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com

FAQ

What investor conferences will Elutia (ELUT) participate in during September 2024?

Elutia will participate in two investor conferences in September 2024: the H.C. Wainwright 26th Annual Global Investment Conference and the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference.

When is Elutia's (ELUT) presentation at the H.C. Wainwright conference?

Elutia's on-demand presentation at the H.C. Wainwright conference will be available starting Monday, September 9, 2024, at 7:00 a.m. ET.

Who will represent Elutia (ELUT) at the upcoming investor conferences?

Dr. Randy Mills, President and CEO, and Matt Ferguson, CFO, will represent Elutia at the upcoming investor conferences.

How can institutional investors meet with Elutia's (ELUT) management during these conferences?

Institutional investors interested in meeting with Elutia's management can reach out to their respective H.C. Wainwright and Lake Street representatives to arrange meetings.